Showing results (1921-1930 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|March 26, 2026
Predictive biomarkers of sustained treatment-free remission in chronic myeloid leukemia: gene expression analyses from the ENESTfreedom and ENESTop studiesJerald P Radich, Shalini Chaturvedi, Islam Sadek, et al.Haematologica|March 19, 2026
Variations in mitochondrial genome as potential prognostic markers in sickle cell diseaseRudra Ray, Haiou Li, Shijinqiu Gao, et al.Haematologica|March 19, 2026
Efficacy and safety of chimeric antigen receptor T-cell therapy for plasma cell leukemiaChenyuan Hu, Na Qi, Wei Wang, et al.Haematologica|April 2, 2026
Relapsed Hodgkin disease: Should all patients receive an autologous stem cell transplant? - the CONAlison J MoskowitzHaematologica|March 26, 2026
Bedside treatment algorithm for safe administration of 24-hour high-dose methotrexate in adult acute lymphoblastic leukemiaAnna-Karin Hamberg, Jessica Schubert, Emma Lennmyr, et al.Haematologica|March 26, 2026
MLL-AF9 expression levels do not instruct lineage fateEmmanouil Kyrloglou, Marco Carretta, Annet Brouwers-Vos, et al.Haematologica|March 26, 2026
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experienceCarmine Liberatore, Virginia Valeria Ferretti, Paola Tacchetti, et al.Haematologica|March 26, 2026
Disrupting adaptive proteostasis to overcome proteasome inhibitor resistanceAnnamaria BrioliHaematologica|April 30, 2026
Immune mediated marrow failure in very young children: horse ATG once again out of the magician's hatMarc Bierings, Kirsten ThusHaematologica|April 16, 2026
Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-ineligible patientsAo Zhang, Benfa Gong, Yuntao Liu, et al.Pageof 816